Maxposure IPO Subscription Live
Maxposure’s IPO saw an overwhelming response with a subscription of 470.75 times. In the retail category, the public issue was subscribed 632.72 times, while it reached 19.75 times in the QIB category and an impressive 675.94 times in the NII category by January 17, 2024, at 12:48 PM
- Last updated on 17/01/2024 12:31:01
Category | Offered | Applied | Times |
---|---|---|---|
QIB | 11,400,000 | 22516000 | 19.75 |
NIB | 880,000 | 594824000 | 675.94 |
RETAIL | 2,048,000 | 1295820000 | 632.72 |
Total | 4,068,000 | 1913160000 | 470.29 |
Maxposure IPO Past Days Subscription Details
Date | QIB | NII* | Retail | Total |
---|---|---|---|---|
Jan 15, 2024 | 3.54 | 68.45 | 112.78 | 72.58 |
Jan 16, 2024 | 6.79 | 176.69 | 298.55 | 190.43 |
Jan 17, 2024 | 19.75 | 644.95 | 625.57 | 459.99 |
Maxposure IPO Shares Offered Details
Maxposure IPO Anchor Investor Allocation Details
A sum of 1.7 million shares will be allocated to anchor investors at a cost of Rs 33 per share.
S.No. | Name of Anchor Investor | No. of Shares Allocated | Bid Price Per Share (Rs.) | Anchor Investor Portion (%) | Total Amount Allocated (Rs.) |
---|---|---|---|---|---|
1 | Tano Investment Opportunities Fund | 304,000 | 33 | 17.88 | 10,032,000 |
2 | Minerva Emerging Opportunities Fund Ltd | 304,000 | 33 | 17.88 | 10,032,000 |
3 | India-Ahead Venture Fund | 788,000 | 33 | 46.35 | 26,004,000 |
4 | Eminence Global Fund Pcc – Eubilia Capital Partners Fund I | 304,000 | 33 | 17.88 | 10,032,000 |
Total | 1,700,000 | 100 | 56,100,000 |
Investing in Initial Public Offerings (IPOs) can be a lucrative opportunity for individuals and institutions alike. To navigate the IPO landscape in India, it’s essential to understand the various investor categories involved. Let’s delve into the distinct roles of Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), Retail Individual Investors (RII), and others.
Qualified Institutional Buyers (QIB): QIBs encompass Financial Institutions, Banks, Foreign Institutional Investors (FIIs), and Mutual Funds registered with the Securities and Exchange Board of India (SEBI). Often, QIBs act as representatives for small investors who prefer channels like mutual funds, insurance ULIP schemes, and pension schemes.
Non-Institutional Investors (NII): This category includes Retail Individual Investors (HNIs), Non-Resident Indians (NRIs), Companies, Trusts, etc., bidding for shares exceeding Rs 2 lakhs. Unlike QIBs, NII investors don’t need SEBI registration. The NII category further splits into two subcategories:
- sNII (Small NII): Targets investors bidding between Rs 2 lakhs to Rs 10 lakhs, with one-third of NII shares reserved for this segment. Often referred to as Small High Net Worth Individuals (sHNI).
- bNII (Big NII): Reserved for investors bidding above Rs 10 lakhs, with two-thirds of NII shares allocated to this category. Known as Big High Net Worth Individuals (bHNI).
Retail Individual Investors (RII): Retail individual investors, including NRIs, who apply for shares up to Rs 2 lakhs fall into the RII category. This segment caters to smaller investors looking to participate in IPOs.
Employee (EMP): Reserved for eligible employees, this category ensures that employees have a dedicated quota in the IPO, providing them with an opportunity to invest in their company.
Others: This category encompasses eligible shareholders and miscellaneous investors, offering them a reserved quota in the IPO.
Understanding the Differences: What sets RII, NII, QIB, and Anchor Investors apart? While QIBs represent institutional entities, NIIs comprise individual and non-institutional entities. The RII category caters to smaller retail investors, ensuring inclusivity in IPO participation. Employee categories prioritize company insiders, fostering a sense of ownership.
Disclaimer: It’s crucial to note that the information provided is sourced from the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to real-time changes. For the latest updates, always refer to the respective websites. The information is for informational purposes only and is provided on an “AS IS” and “AS AVAILABLE” basis, without any warranties. Recipients should conduct their research and seek professional advice before making investment decisions.